Navigation Links
GenVec Reports Third Quarter 2012 Financial Results
Date:11/9/2012

GAITHERSBURG, Md., Nov. 9, 2012 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the three months and nine months ended September 30, 2012.

GenVec reported a net loss of $4.0 million, or $0.31 per share for the three months ended September 30, 2012, compared with a net loss of $1.5 million, or $0.11 per share, in the comparable quarter of 2011. For the nine months ended September 30, 2012, GenVec's net loss was $10.9 million, or $0.84 per share, compared to a net loss of $4.9 million, or $0.38 per share, for the nine months ended September 30, 2011. 

"The third quarter was very productive for GenVec as we made important advancements in our vaccine programs as well as our collaboration with Novartis to develop treatments for hearing loss utilizing our core technology," commented Cynthia Collins, GenVec's President and CEO. "Specifically, we presented important data on our RSV program, entered into a new collaboration for our malaria program, and aligned our cost structure with our business strategy. We are encouraged by emerging data and new contracts that will leverage GenVec's proprietary adenoviruses that are capable of generating a broad immune response while avoiding the problems of vector specific immunity that have hampered other vectored vaccines."

Recent Highlights

  • Promising data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the 8th Annual International Respiratory Syncytial Virus Symposium, demonstrating that GenVec's pre-clinical, universal RSV vaccine candidate is highly immunogenic and produces durable and broad protection from a single intramuscular administration.  Protection in cotton rat and mouse models was characterized by functional RSV neutralizing antibodies and no disease potentiation was observed.
  • GenVec completed a pre-IND meeting with
    '/>"/>

  • SOURCE GenVec, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. GenVec Reports Second Quarter 2012 Financial Results
    2. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
    3. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
    4. GenVec Reports Inducement Award
    5. GenVec Appoints Cynthia Collins as President and CEO
    6. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
    7. HeartWare Reports Third Quarter 2012 Results
    8. Nephros Reports Third Quarter 2012 Financial Results
    9. China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012
    10. CareFusion Reports Preliminary First Quarter Fiscal 2013 Results
    11. Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... YORK , September 22, 2014 ... Market Report on "Global Market Study on Ophthalmic Devices: ... by 2020," the global ophthalmic devices market was valued at USD ... at a CAGR of 6.5% from 2014 to 2020, ... in 2020. Browse the full Global Market Study ...
    (Date:9/22/2014)...  AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... machines, announced today that they are starting production of ... unit is designed for placement inside optical shops and ... statistics, there are over 20,000 optical stores in ... world,s first automated kiosk dedicated to cleaning and sanitizing ...
    (Date:9/22/2014)... 2014  Neuralstem, Inc. (NYSE MKT: CUR) announced that ... Emory University, presented long-term follow up data on the ... in the treatment of amyotrophic lateral sclerosis (ALS or ... at the Annual Symposium on ALS of the Foundation ... Friday, and was not open to the public, covered ...
    Breaking Medicine Technology:Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Opticwash Pro Enables Optical Retailers to Generate New Revenues and Customer Traffic through a Unique Eyeglass Cleaning System 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4
    ... Oncimmune ® LLC , maker of EarlyCDT™-Lung , a ... and early detection of lung cancer , today announced ... International Conference May 13 - 18 in Denver will collectively ...  Oncimmune,s EarlyCDT-Lung test uses a panel of tumor ...
    ... (Polaris) today announced that the Company will highlight clinical ... ADI-PEG 20, during a symposium held on Tuesday, May ... Taiwan. Details about Polaris, upcoming pivotal Phase ... (HCC) will be presented by the principal investigator, Ghassan ...
    Cached Medicine Technology:Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 2Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 3Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 4Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers 5Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 2Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan 3
    (Date:9/22/2014)... Jose, California (PRWEB) September 22, 2014 ... Respiratory care market occupies a significant presence in ... the most widespread healthcare problems globally. Key factors ... unhealthy lifestyle habits such as smoking; increasing levels ... COPD; and expanding base of aging population vulnerable ...
    (Date:9/22/2014)... September 22, 2014 The report ... Spain) aesthetic lasers and energy devices market revenue ... Body Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) ... also provides company shares by revenue for the ... Scope,     Information on market size ...
    (Date:9/22/2014)... 2014 The Spa Standard, announced today ... the start-up in developing content and courses for their ... company over 15 years of experience in massage therapy, ... management with companies including Orient Express Hotels and the ... of educator, Jenny gained extensive industry insight through planning, ...
    (Date:9/22/2014)... of modern medical development is medical imaging which ... monitoring, disease detection and treatments. The devices and ... without the use of image processing, pattern recognition, ... are areas of active research development which are ... the areas. A partial list of the important ...
    (Date:9/22/2014)... MA, September 22, 2014 The American Association ... guidelines for the prevention and treatment of perioperative ... thoracic surgical procedures. The guidelines are published in ... . , "These guidelines have the potential to ... of patients who undergo lung surgery in the ...
    Breaking Medicine News(10 mins):Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 3Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 4Health News:The Spa Standard Appoints Vice-President of Content and Course Development 2Health News:Researchers uncover the frontiers of R&D in medical imaging 2Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 2Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 3Health News:New guidelines issued for managing peri- and postoperative atrial fibrillation 4
    ... Doheny HealthDay Reporter , FRIDAY, Aug. 5 (HealthDay ... physically active, a new study finds that performance often trumps ... gained from about six months of exercise proved more satisfying ... the research. This suggest that with advancing years, a shift ...
    ... In summer, more dishes like gazpacho a cold soup containing ... new study has revealed that ingredients, vitamin C content as ... mixture, meaning that it should be eaten immediately after preparation., ... vitamin loss? A new study has examined gazpacho, one of ...
    ... --,Smokers who take a multivitamin pill may think they can ... affects of cigarettes, according to a new study. Researchers ... will reduce their risk of cancer, allowing them to light ... a virtuous behavior for a subsequent indulgence, known as the ...
    ... , THURSDAY, Aug. 4 (HealthDay News) -- People living ... the "Stroke Belt" are known to have significantly higher rates ... research reveals these residents are also at greater risk for ... "In 2010, we examined death rates from sepsis across ...
    ... discovery by scientists at Duke University Medical Center and ... effective combination of drug therapy to treat the second ... scientists have been looking for the primary cancer genes ... two chromosomes that held the probable mutations, but not ...
    ... 4 (HealthDay News) -- A map of the genetic mutations ... appears to reveal the biological cause of the tumors, researchers ... in seven samples of tissue from oligodendroglioma tumors, and concentrated ... previously associated with those types of tumors. The genes ...
    Cached Medicine News:Health News:With Age, Focus on Body Shifts From Appearance to Function 2Health News:With Age, Focus on Body Shifts From Appearance to Function 3Health News:Gazpacho ingredients lose vitamin C during preparation 2Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:U.S. 'Stroke Belt' May Also Be 'Sepsis Belt' 2Health News:Elusive gene mutations found for malignant brain tumor 2Health News:Scientists May Have Found Missing Link to Common Brain Cancer 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: